Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
about
Fibrotic and sclerotic manifestations of chronic graft-versus-host diseaseThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseAllogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease.Diagnosis and treatment of constrictive bronchiolitis.Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationThe acute impact of a hematopoietic allograft on lung function and inflammation: a prospective observational study.Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.How I treat late effects in adults after allogeneic stem cell transplantation.Role of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations.Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host diseaseA "window of opportunity" for patients with late-onset pulmonary dysfunction after allogeneic hematopoietic cell transplantationNational Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage aFailure-free survival in a prospective cohort of patients with chronic graft-versus-host disease.Evaluating the impact of antithymocyte globulin on lung function at 1 year after allogeneic stem cell transplantationBlood and marrow transplant clinical trials network state of the Science Symposium 2014Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an updateStable long-term pulmonary function after myeloablative double cord blood transplant.Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.Pulmonary rehabilitation for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.Pulmonary hypertension associated with bronchiolitis obliterans after hematopoietic stem cell transplantation.Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.The lung function score and its components as predictors of overall survival and chronic graft-vs-host disease after allogeneic stem cell transplantation.Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement.Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationPreventing and managing bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation.Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD.Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options.Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome?A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation.Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment.Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation.
P2860
Q27024147-13908629-5B70-47FA-B33E-265B7F247472Q28076264-463E751B-48BF-40DC-BCCA-B5F90F57102CQ33638349-BFF59B44-AC4E-4CDA-9635-8C4C999C5548Q34167618-233AA7BC-AC10-47CF-8E95-06E90602DEB4Q34175690-FD7766BD-B51B-492C-87FE-AF4309505B1BQ34545875-819C0C00-A14E-4C38-B9F9-87E138AC626DQ34700473-A567C21E-BFA7-4BD0-8299-AA43923A8E4CQ34707208-52D93555-ADEB-4F43-BC06-14A17B6236E8Q34924856-9A56275D-33C7-4E94-AA21-1A4A3BA385F6Q34969868-107FE154-0611-4350-B6A6-0B69D33332B9Q35085226-2645A85D-465D-4FB8-AC82-67AA528AD64BQ35293711-0FA8279A-85AC-43BA-B629-C64A52A1B569Q35445239-FE4CC30A-1E9D-4037-9934-5C52E7281231Q35549037-AD7992B5-4CA2-4DA9-A4A4-6BBFA80162BEQ35571058-F479E1D7-3BA1-4FED-8947-4BA37777CF2CQ35574785-9195C9AD-23B3-4543-98F6-1823841F9E49Q35591760-CE656527-DD72-4A68-A253-064EC652616CQ35664284-97984166-9450-4DA9-9DC4-48F86DF466E0Q35672924-5F07229D-1C2A-488E-A66A-DFB7D81B212BQ35757247-5F683ED8-BB46-45FA-981C-47941DF18D9EQ36044412-95712CAA-B26A-4976-A78D-91C4AE29E272Q36540556-DF78A6FD-C65E-42BC-995A-2E56E31E5152Q36541552-8452BF62-7EF6-4B9C-A48F-22986322476FQ36707835-3AC8E993-124B-4FA0-8F19-65E652268C7CQ36712018-F223B346-5587-4655-8910-1731E801E8FCQ36747224-D5F74A49-24D1-4290-9EFB-B1B0B6B3927AQ36766324-EF0DFC62-8AB4-47C1-9A55-981C6DDC789FQ36886930-212649EB-036F-4C40-861B-C76D7D4EF786Q37146140-7A8935A9-45BE-4F93-A26B-C023957C69CBQ37276584-59AA8723-37A3-4559-AB86-C98FE74FD8ACQ37609903-E42D087F-E849-4F87-A417-198D2FE8F185Q37846706-04E32660-526F-4427-AF93-8AB14BB674DDQ37858415-E38F43E5-EB7E-402F-8C2D-1666FD4FE908Q37923305-35BB0BBB-7424-4F7F-8BC3-E8DB1E653E46Q38392246-48CFFF42-751A-4795-99C7-E48654C458C6Q38502469-8F4E4245-B2DA-465F-9BE6-DF44DAFB5CAAQ39441064-8C7538AF-93DE-4CCC-B959-F47A6366AE03Q40280061-F9677E3A-4FBE-4EE1-91C3-39221C072F54Q40385568-51D54A39-D64B-498B-9270-F60CA5034BCAQ40787485-3C91B302-17BD-48D5-89DC-7E710CC94ED3
P2860
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
@en
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
@nl
type
label
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
@en
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
@nl
prefLabel
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
@en
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
@nl
P356
P1476
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
@en
P2093
Jason W Chien
Steven Z Pavletic
P304
P356
10.1001/JAMA.2009.1018
P407
P577
2009-07-01T00:00:00Z